Jodi Larsen
Family · Palm Bay, FLNPI 1861931032
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Lumenis BE Inc at 25.6% of the total. 2025 is the largest year on record at $1,399, 2.6 times the $547 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $24.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$1K
- Novo Nordisk$478
- AstraZeneca$375
- AbbVie$310
- Lilly USA, LLC$284
- Merck$220
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,531100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 1 | $1,159 |
| Novo Nordisk | 43 | $478 |
| AstraZeneca | 25 | $375 |
| AbbVie | 22 | $310 |
| Lilly USA, LLC | 14 | $284 |
| Merck | 11 | $220 |
| Bayer | 10 | $203 |
| Harmony Biosciences LLC | 2 | $166 |
| GSK | 9 | $154 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Daiichi Sankyo Inc. | 1 | $124 |
| Gilead | 1 | $124 |
| Amgen | 8 | $124 |
| Pfizer | 3 | $110 |
| Novartis | 6 | $103 |
| Boehringer Ingelheim | 4 | $68 |
| Exact Sciences | 3 | $60 |
| Eisai Inc. | 3 | $53 |
| Dexcom, Inc. | 3 | $44 |
| Corcept Therapeutics | 2 | $40 |
| Astellas Pharma US Inc | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Theratechnologies Inc. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,531 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other family in Palm Bay
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.